This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Larsson, O. Articles by Polunovsky, V. A. Search for Related Content PubMed PubMed Citation Articles by Larsson, O. Articles by Polunovsky, V. A.

Eukaryotic Translation Initiation Factor 4E–Induced Progression of Primary Human Mammary Epithelial Cells along the Cancer Pathway Is Associated with Targeted Translational Deregulation of Oncogenic Drivers and Inhibitors

Departments of ¹ Medicine and ² Surgery, University of Minnesota, Minneapolis, Minnesota

Requests for reprints: Vitaly A. Polunovsky, Department of Medicine, University of Minnesota, 420 Delaware Street, Minneapolis, MN 55455. Phone: 612-626-2112; Fax: 612-625-2174; E-mail: polun001{at}umn.edu or Peter B. Bitterman, Department of Medicine, University of Minnesota, 420 Delaware Street, Minneapolis, MN 55455. Phone: 612-624-5175; Fax: 612-625-2174; E-mail: bitte001{at}umn.edu.

Pathologic redirection of translational control by constitutive activation of eukaryotic translation initiation factor 4F (eIF4F), the cap-dependent translation initiation apparatus, is an obligatory step in oncogenesis; however, its mechanism remains undefined. Here, we simulate this pro-oncogenic state by overexpressing eIF4E, the rate-limiting component of eIF4F, in primary human mammary epithelial cells (HMECs) and examine the resultant changes in cell biology and gene expression profiles of total and polyribosome-bound mRNA genome wide. Overexpressed eIF4E rescues primary HMECs from telomere-independent growth arrest and disables checkpoints governing S-phase entry as well as apoptosis in HMECs immortalized by telomerase, imparting cells with proliferative and survival autonomy. Although the transcriptional response to increased eIF4E was modest, the translational response was large, selective, and bidirectional. In addition to translational activation of known and novel eIF4E-responsive oncogenic drivers regulating cell growth and survival, our data unveil previously unrecognized cellular defenses including translational activation of tumor suppressors, translational repression of transcripts enriched with miRNA target sites, and translational modulation of genes governing translation itself. These findings provide insight into the proneoplastic and compensatory mechanisms embedded in the oncogenic translational program. They support a model whereby deregulated eIF4E moves human epithelial cells along the cancer pathway by profoundly altering ribosomal recruitment to cancer-related transcripts, and eIF4E-modified cells counter these potentially oncogenic alterations with a compensatory translational mechanism that mitigates acquisition of malignancy. [Cancer Res 2007;67(14):6814–24]

This article has been cited by other articles:

				Y. Y. Kim, L. Von Weymarn, O. Larsson, D. Fan, J. M. Underwood, M. S. Peterson, S. S. Hecht, V. A. Polunovsky, and P. B. Bitterman Eukaryotic Initiation Factor 4E Binding Protein Family of Proteins: Sentinels at a Translational Control Checkpoint in Lung Tumor Defense Cancer Res., November 1, 2009; 69(21): 8455 - 8462. [Abstract] [Full Text] [PDF]

				D. Fan, P. B. Bitterman, and O. Larsson Regulatory element identification in subsets of transcripts: Comparison and integration of current computational methods RNA, August 1, 2009; 15(8): 1469 - 1482. [Abstract] [Full Text] [PDF]

				C. Y. Zou, K. D. Smith, Q.-S. Zhu, J. Liu, I. E. McCutcheon, J. M. Slopis, F. Meric-Bernstam, Z. Peng, W. G. Bornmann, G. B. Mills, et al. Dual targeting of AKT and mammalian target of rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumor Mol. Cancer Ther., May 1, 2009; 8(5): 1157 - 1168. [Abstract] [Full Text] [PDF]

				G. Grech, M. Blazquez-Domingo, A. Kolbus, W. J. Bakker, E. W. Mullner, H. Beug, and M. von Lindern Igbp1 is part of a positive feedback loop in stem cell factor-dependent, selective mRNA translation initiation inhibiting erythroid differentiation Blood, October 1, 2008; 112(7): 2750 - 2760. [Abstract] [Full Text] [PDF]

				K. J. Mavrakis, H. Zhu, R. L.A. Silva, J. R. Mills, J. Teruya-Feldstein, S. W. Lowe, W. Tam, J. Pelletier, and H.-G. Wendel Tumorigenic activity and therapeutic inhibition of Rheb GTPase Genes & Dev., August 15, 2008; 22(16): 2178 - 2188. [Abstract] [Full Text] [PDF]

				A. Soni, A. Akcakanat, G. Singh, D. Luyimbazi, Y. Zheng, D. Kim, A. Gonzalez-Angulo, and F. Meric-Bernstam eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling Mol. Cancer Ther., July 1, 2008; 7(7): 1782 - 1788. [Abstract] [Full Text] [PDF]

				S. Pervin, A. H. Tran, S. Zekavati, J. M. Fukuto, R. Singh, and G. Chaudhuri Increased Susceptibility of Breast Cancer Cells to Stress Mediated Inhibition of Protein Synthesis Cancer Res., June 15, 2008; 68(12): 4862 - 4874. [Abstract] [Full Text] [PDF]